Literature DB >> 21934230

Primary cardiac diffuse large B-cell lymphoma with activated B-cell-like phenotype.

Vijaya Gadage1, Seema Kembhavi, Prabhash Kumar, Tanuja Shet.   

Abstract

Primary cardiac lymphoma (PCL) is a rare and fatal disorder. It may often mimic other common cardiac tumors like cardiac myxoma because of similarities in the clinical presentation. We report a case of PCL of diffuse large B-cell type, in a 38-year-old, immunocompetent male who presented with superior vena cava syndrome that was excised as a myxoma. Histology revealed a large cell population diffusely and strongly expressing CD45, CD20, MUM1/IRF4 and FOXP1 hinting at an activated B-cell (ABC)-like phenotype. After four cycles of Rituximab with CHOP (cyclophosphamide, hydroxydaunorubicin, Oncovin, and prednisolone) the tumor regressed completely but the patient had a relapse and subsequently succumbed to the disease confirming the aggressive nature. The aggressive behavior of PCL may be possibly linked to its ABC-like origin.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21934230     DOI: 10.4103/0377-4929.85104

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  4 in total

1.  Primary Cardiac Lymphoma in an Immunocompetent 71-Year-Old Man.

Authors:  Claudia Montanaro; Ferdinando Loiacono; Gabriele Fragasso; Francesco De Cobelli; Marco Foppoli; Alberto Margonato
Journal:  Tex Heart Inst J       Date:  2015-12-01

2.  Analysis of computed tomography and pathological observations of non-Hodgkin lymphomas with peritoneal, omental and mesenteric involvement.

Authors:  Yuan-Gang Qi; Ze-Hui Fang; Yong Huang
Journal:  Exp Ther Med       Date:  2015-01-23       Impact factor: 2.447

3.  Cardiac Involvement by HIV-Associated DLBCL.

Authors:  Charles T Mupamombe; Jude Noel; Derek B Laskar; Liza Valdivia
Journal:  Case Rep Med       Date:  2018-07-24

Review 4.  Targeting the forkhead box protein P1 pathway as a novel therapeutic approach for cardiovascular diseases.

Authors:  Xin-Ming Liu; Sheng-Li Du; Ran Miao; Le-Feng Wang; Jiu-Chang Zhong
Journal:  Heart Fail Rev       Date:  2022-01       Impact factor: 4.214

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.